Table 2.
Scale group | N | Symptom scale | Chemical intolerance scale | Other intolerance scale | Life Impact scale | ||||
---|---|---|---|---|---|---|---|---|---|
Median (IQR)** | Alpha*** | Median (IQR) | Alpha | Median (IQR) | Alpha | Median (IQR) | Alpha | ||
Patient sample | 189 | 47 (30–64) | 0.84 | 80 (62–91) | 0.91 | 34 (20–53) | 0.83 | 64 (45–80) | 0.89 |
Population | 1309 | 11 (5–23) | 0.86 | 13 (4–30) | 0.92 | 10 (3–19) | 0.77 | 2 (0–8) | 0.86 |
| |||||||||
Population* | |||||||||
−30 | 201 | 12 (5–23) | 0.83 | 11 (4–24) | 0.87 | 11 (3–19) | 0.64 | 4 (0–10) | 0.74 |
30–40 | 218 | 11 (4–21) | 0.85 | 15 (5–31) | 0.93 | 11 (5–22) | 0.79 | 2 (0–8) | 0.86 |
40–50 | 288 | 11 (6–22) | 0.89 | 14 (5–30) | 0.92 | 11 (5–18) | 0.79 | 2 (0–8) | 0.90 |
50–60 | 312 | 12 (5–23) | 0.86 | 14 (4–32) | 0.94 | 8 (3–17) | 0.78 | 1 (0–9) | 0.87 |
60− | 290 | 10 (4–23) | 0.86 | 12 (1–29) | 0.93 | 5 (0–17) | 0.75 | 0 (0–5) | 0.81 |
*Population sample grouped by age.
**Interquartile range.
***Cronbach's alpha.